Anthropic Could Beat OpenAI to Wall Street by Over a Year

Anthropic could reportedly seek up to $100 billion in an IPO at a valuation near $2 trillion, but that would cover only about 19% of its roughly $518 billion in multi-year infrastructure commitments. The proposed valuation equates to about 33 times estimated 2026 sales of $60 billion; meanwhile, 83% of 2025 revenue was usage-based while about 80% of infrastructure obligations are effectively locked in. OpenAI, valued at $852 billion after a $122 billion private funding round, is reportedly seeking at least $30 billion more privately and has ruled out a 2026 IPO.

Analysis

The key risk is not simply a rich IPO multiple; it is operating leverage running in reverse. If customer usage slows, revenue can reset faster than reserved compute costs, pressuring cash conversion before reported growth necessarily falters. But treat the obligation figure as a ceiling on flexibility, not proof every dollar becomes stranded: the S-1 should clarify utilization, cancellation, resale, and minimum-payment terms. The third-party 2026 sales estimate is not company guidance, and the stated valuation leaves little room for execution slippage if it holds through pricing.

Near term (days), a first-mover listing could attract scarcity capital and lift sentiment toward AI infrastructure, but the initial valuation may matter more than the IPO headline. Over 1–3 months, watch the S-1, final offer valuation, customer concentration, gross margin, cash burn, and capacity utilization; these will determine whether growth translates into self-funding economics. Over 6–18 months, a utilization downturn or financing gap could shift risk to cloud counterparties and lenders. Conversely, strong paid usage and improving unit economics would validate the capacity buildout.

For Broadcom (AVGO), potential financing is two-sided: it may support TPU demand and custom-silicon economics, while adding counterparty and capital exposure. The reported facility is not enough to establish material consolidated credit risk; terms, recourse, and exposure relative to Broadcom’s balance sheet need verification. Contrarian angle: large commitments may secure scarce capacity ahead of demand, so headline obligations alone do not prove overbuilding. The thesis is falsified by disclosed improving utilization and cash margins, or strengthened by rising commitments alongside weaker usage and worsening cash conversion.

Key Decisions for Investors

• Do not buy the Anthropic IPO solely on first-mover scarcity. If pricing approaches the reported valuation, wait for the S-1 and offering terms; consider participation only if verified unit economics, customer diversification, and capacity flexibility support the growth case.
• Keep AVGO at monitor/hold rather than trade on the reported financing alone. Reassess when facility terms and Broadcom’s maximum exposure are disclosed; deteriorating credit terms without corresponding TPU demand would be a negative catalyst.
• Set an alert for the S-1 and first post-listing results: track usage growth versus reserved-capacity utilization, gross margin, and operating cash burn. Weakening usage or cash conversion while commitments remain firm would favor avoiding the stock; improving margins and utilization would invalidate the downside thesis.